Matthew Wikler Matinas Bio Pharma Holdings, Inc. (MTNB) insider trading activity

Matthew Wikler is Director of Matinas BioPharma Holdings, Inc.. Currently has a direct ownership of 290,472 shares of MTNB, which is worth approximately $151,045. The most recent transaction as insider was on Dec 31, 2021, when has been sold 7,859 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 290K

0% 3M change

0% 12M change

Total Value Held $151,045

MATTHEW WIKLER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 31 2021	BUY Grant, award, or other acquisition	-	7,859 Added 2.63%	290,472 Common Stock
Sep 30 2021	BUY Grant, award, or other acquisition	-	6,106 Added 2.11%	282,613 Common Stock
Jun 30 2021	BUY Grant, award, or other acquisition	-	10,244 Added 3.57%	276,507 Common Stock
Jun 19 2021	BUY Conversion of derivative security	-	12,000 Added 4.31%	266,263 Common Stock, par valu...
Jun 19 2021	BUY Other acquisition or disposition	-	2,400 Added 0.94%	254,263 Common Stock, par valu...
Mar 31 2021	BUY Grant, award, or other acquisition	-	7,560 Added 2.91%	251,863 Common Stock
Dec 31 2020	BUY Grant, award, or other acquisition	-	11,673 Added 4.56%	244,303 Common Stock
Sep 30 2020	BUY Grant, award, or other acquisition	-	20,725 Added 8.18%	232,630 Common Stock

Matthew Wikler

Director

Bedminster,, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MTNB shares.

Notify only if

Value

Insider Trading

Get notified when an Matinas Bio Pharma Holdings, Inc. insider buys or sells MTNB shares.

Notify only if

Operation

Value

Type

News

Receive news related to Matinas BioPharma Holdings, Inc.

Track Activities on MTNB

Account